PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR — Fluticasone Importer Profile
Pharmaceutical Importer · #3 buyer for Fluticasone · $4.3M import value · 96 shipments · TURKEY · DGFT Verified
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR is the #3 importer of Fluticasone from India with $4.3M in import value and 96 verified shipments. PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR holds a 2.4% market share in Fluticasone imports based in TURKEY. The company sources from 2 verified suppliers across 34 formulations shipped to 2 countries. Overall, PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR imports 5 pharmaceutical products worth $11.8M across 2 therapeutic categories.
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR — Fluticasone Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Fluticasone to PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR?
Verified from 96 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $3.3M | 77 | 78.0% |
| MEDISPRAY LABORATORIES PRIVATE LIMITED | $939.2K | 19 | 22.0% |
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR sources Fluticasone from 2 verified Indian suppliers based on 96 customs records. The primary supplier is CIPLA LIMITED accounting for 78.0% of imports.
How Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR Compare to Nearest Fluticasone Importers?
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | APOTEX INC | CANADA | $7.9M | 182 | $43.2K |
| 2 | MYLAN IRELAND LIMITED | NETHERLANDS | $6.8M | 136 | $50.0K |
| 3 | PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR ★ | TURKEY | $4.8M | 96 | $50.0K |
| 7 | MEDPRO PHARMACEUTICA PTY LTD | SOUTH AFRICA | $3.3M | 65 | $50.0K |
| 13 | CIPLA MAROC | MOROCCO | $2.1M | 43 | $50.0K |
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR ranks #3 among 664 Fluticasone importers from India. Average shipment value of $50.0K compared to the market average of $83.7K. The closest competitors by value are APOTEX INC and MYLAN IRELAND LIMITED.
Where Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR Import Fluticasone To?
Destination countries from 96 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| TURKEY | $3.7M | 85 | 87.8% |
| UNITED ARAB EMIRATES | $521.6K | 11 | 12.2% |
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR imports Fluticasone to 2 countries. The primary destination is TURKEY receiving 87.8% of shipments worth $3.7M.
What Fluticasone Formulations Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR Import?
| Formulation | Value | Shipments |
|---|---|---|
| FLOHALE 250 HFA INHALER FLUTICASONE PRO | $856.6K | 24 |
| SEROFLO 250 HFA INHALER (SALMETEROL XINAFOATE 25MCG+FLUTICASONE PROPIONATE 250MCG ) (1 X 120 MD) | $753.5K | 17 |
| FLOHALE 125 HFA INHALER (FLUTICASONE PRO | $571.6K | 12 |
| SEROFLO 125 HFA INHALER (WITH DOSE INDICATOR) (SALMETEROL XINAFOATE 25MCG+FLUTICASONE PROPIONATE 125MCG ) (1 X 120 MD) | $317.5K | 7 |
| FLOHALE 125 HFA INHALER FLUTICASONE PRO | $200.0K | 4 |
| FLUTICORT PLUS -250 HFA INHALER WITH DOSE INDICATOR 120 MD (SALMETEROL XINAFOATE 25 MCG + FLUTICASONE PROPIONATE 250 M | $150.0K | 3 |
| SEROFLO 250 HFA SYNCHROBREATHE SB (SALMETEROL XINAFOATE 25MCG+FLUTICASONE PROPIONATE 250MCG) | $100.0K | 2 |
| FLOHALE 250 HFA INHALER (FLUTICASONE PRO | $50.0K | 1 |
| SEROFLO 250 HFA INHALER SALMETEROL XINAFOATE 25MCG FLUTICASONE PROPIONATE 250MCG 17926 PACK 1X120MD | $50.0K | 1 |
| SEROFLO 250 HFA INHALER SALMETEROL XINAFOATE 25MCG FLUTICASONE PROPIONATE 250MCG 17895 PACK 1X120MD | $50.0K | 1 |
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR imports 34 distinct Fluticasone formulations from India. The top formulation is FLOHALE 250 HFA INHALER FLUTICASONE PRO with 24 shipments worth $856.6K.
Who Are the Top Buyers of Fluticasone from India and How Much Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR Import?
India exported $55.6M worth of Fluticasone through 9,009 shipments from 239 suppliers to 123 countries, serving 664 buyers globally. PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR imports $4.3M of this total, accounting for 2.4% of India's Fluticasone exports with 96 shipments from TURKEY. This is verified from 96 customs shipment records covering 34 distinct formulations.
What Is the Average Order Value for PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR's Fluticasone Imports?
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR's average Fluticasone order value is $44.5K per consignment, based on 96 shipments totaling $4.3M. PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR is based in TURKEY and ranks #3 among all Fluticasone importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Fluticasone to PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR?
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR sources Fluticasone from 2 verified Indian suppliers: CIPLA LIMITED ($3.3M, 78.0%), MEDISPRAY LABORATORIES PRIVATE LIMITED ($939.2K, 22.0%). This is based on 96 customs records.
How Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR Compare to Other Fluticasone Importers?
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR ranks #3 among 664 Fluticasone importers from India with a 2.4% market share. The top 3 importers are MYLAN IRELAND LTD ($17.4M), APOTEX INC ($7.9M), MYLAN IRELAND LIMITED ($6.8M). PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR processed 96 shipments from TURKEY.
What Other Respiratory Products Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR Import?
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR also imports these respiratory products. Each links to the detailed product page.
About PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR imports 5 products worth $11.8M. Beyond Fluticasone, top products include Salmeterol, Salbutamol, Methotrexate, Tiotropium. View the complete PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fluticasone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fluticasone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR's capped import value divided by total capped export value for Fluticasone across all Indian exporters.
- 5.Verified Records: This page is backed by 96 individual customs records matching PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR importing Fluticasone, covering 34 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 664+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fluticasone Import Data for PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR
Access order-level details, pricing data, supplier connections, and competitive analysis for PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR's Fluticasone imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR
Full Company Profile →
5 products · $11.8M total trade · 2 categories
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR × Fluticasone
Verified from customs records
Company Overview
Top Products by PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fluticasone. For current order-level data, contact TransData Nexus.